CERN Foundation
Image of Ependymoma survivor Ashleigh with her family.

My Journey with Myxopapillary Ependymoma

Ashleigh’s journey with ependymoma is one of resilience, transformation, and purpose. In sharing her story, she opens up about the pain of a delayed diagnosis, the daily challenges she continues to face, and how she has chosen to move forward by turning hardship into hope.

"This diagnosis has changed every aspect of my life — from my physical abilities to my mental resilience. I live with increased pain and anxiety, but I’ve also found a renewed sense of purpose. I’ve become motivated to achieve more and pursue a career I care deeply about — patient advocacy, especially in the rare disease space. To those newly diagnosed, my advice is this: allow yourself to grieve. Feel everything — anger, sadness, fear. Then rise. Advocate for yourself. Connect with others. Learn as much as you can. There is no 'right' way to cope, and healing isn’t linear. But in time, you’ll find strength in the knowledge, the community, and within yourself."

Through grief and growth, Ashleigh has discovered her voice as a passionate advocate. Her message to others is one of empowerment: feel it all, rise, and know you are not alone.

READ ASHLEIGH'S STORY
 
 

EPENDYMOMA AWARENESS DAY

International Ependymoma Awareness Day Virtual Webinar

Image of Emily, a patient who will be featured in the awareness day webinar in June.

International Ependymoma Awareness Day will be commemorated with a virtual webinar featuring stories from ependymoma survivors, education from experts, community polls, and more. Join us for a one-hour webinar on Zoom at 12 p.m. ET on Tuesday, June 10.

Webinar overview:

  • Hear from Dr. Mariella Filbin, Co-Director, Brain Tumor Center of Excellence at Dana Farber Cancer Institute, about the importance of biomarker testing for ependymoma
  • Learn the importance of a second opinion when facing a rare disease diagnosis
  • Watch a video of Emily Meyer’s inspirational story and butterfly release
REGISTER TODAY
 
 
A little boy holds a butterfly, a symbol of hope for brain tumor survivors.

Support the Ependymoma Fund for Research and Education

With your generous support, we will continue to expand our efforts to improve the care and outcome of people with ependymoma.

MAKE A GIFT
 
CERN Foundation Logo.

The CERN Foundation and the The CERN Foundation, a program of the National Brain Tumor Society, helps people with ependymoma and advances ependymoma research toward the development of new and better treatments through the creation of the Ependymoma Fund for Research and Education. Donations to the Ependymoma Fund for Research and Education will be made on the NBTS website and used to support research efforts that will benefit both ependymoma patients and research through CERN. Emphasis will be placed on CERN’s historical model of supporting work that translates basic science into clinical practice. The fFund will also address overcoming barriers to clinical trial accrual and the development of new clinical studies for ependymoma patients. Additional funds will be used to support educational efforts through print, media, and awareness events. The collaborative Ependymoma Fund will continue CERN’s practice and tradition of involving and collaborating with other scientists, medical providers, foundations and supporters of ependymoma research.

LEARN MORE
 
 

CONNECT WITH US!  

Visit NBTS on Facebook. Visit NBTS on Twitter. Visit NBTS on YouTube.
 

National Brain Tumor Society unrelentingly invests in, mobilizes, and unites our community to discover a cure, deliver effective treatments, and advocate for patients and care partners. Our vision is to conquer and cure brain tumors—once and for all.

Privacy PolicyUpdate Email Preference or Unsubscribe

Update email preferences or unsubscribe

© National Brain Tumor Society - All Rights Reserved.
55 Chapel Street, Suite 006, Newton, MA 02458
617.924.9997 • Contact Us